Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2024PharmaceuticalsOpen Access

Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus

View Full Paper
Ask AI
Bookmark
Share

Authors

SAShatha M. AlobaidRARahaf M. AlshahraniAAAsma S. Alonazi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alobaid et al. (2024) studied this question.

synapsesocial.com/papers/68e73cb8b6db6435876b6196https://doi.org/10.3390/ph17030374
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide protects cardiac function in diabetic rats through the PPARα pathway2018 · 35 citations
  2. 2Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats2018 · 73 citations
  3. 3Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-12023 · 4 citations
  4. 4Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy2019 · 25 citations
  5. 5The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy2025 · 15 citations